1. Min SK. Modern psychiatry. 3th ed. Seoul: Ilchokak;1995.
9. Boehmer U. Twenty years of public health research: inclusion of lesbian, gay, bisexual, and transgender populations. Am J Public Health. 2002; 92:1125–1130.
10. Harcourt J. Current issues in lesbian, gay, bisexual, and transgender (LGBT) health: introduction. J Homosex. 2006; 51:1–11.
13. van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf). 1997; 47:337–342.
14. Sequeira GM, Chakraborti C, Panunti BA. Integrating lesbian, gay, bisexual, and transgender (LGBT) content into undergraduate medical school curricula: a qualitative study. Ochsner J. 2012; 12:379–382.
15. Dahl M, Feldman JL, Goldberg J, Jaberi A, Bockting W, Knudson G. Endocrine therapy for transgender adults in British Columbia: suggested guidelines. Vancouver, BC: Vancouver Coastal Health;2006.
16. Obedin-Maliver J, Goldsmith ES, Stewart L, White W, Tran E, Brenman S, et al. Lesbian, gay, bisexual, and transgender-related content in undergraduate medical education. JAMA. 2011; 306:971–977.
17. Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA 3rd, Read JS, et al. Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old. J Acquir Immune Defic Syndr. 2010; 55:197–204.
18. Goldberg J, Rouse BS, Ashbee O, Lindenberg D, et al. Vancouver Coastal Health Authority. Transcend Transgender Support & Education Society. Recommended framework for training in transgender primary medical care. Vancouver, BC: Vancouver Coastal Health;2006.
19. Safer JD. Transgender medical research, provider education, and patient access are overdue. Endocr Pract. 2013; 19:575–576.